The Cigna Group stands poised to reap the rewards of utilization normalization in the back-half of the decade. Specifically, the company is taking steps to reduce exposure to government programs such as Medicare that have been stingy with rate increases in recent years and to address sources of member abrasion such as prescription costs and accessibility of care in an effort to drive commercial business growth in what is a highly competitive industry.
